Clinical Trial Update: HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hepatic arterial infusion chemotherapy (HAIC) combined with bevacizumab and toripalimab for advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Neoplasms

Drugs mentioned

• Bevacizumab (bevacizumab)
• HAIC (hepatic artery infusion chemotherapy)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma, Bevacizumab | Phase 2 | Status: UNKNOWN